Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hung Q. Ly, MD"'
Autor:
Dennis T. Ko, MD, MSc, Tareq Ahmed, MPH, Peter C. Austin, PhD, Warren J. Cantor, MD, Paul Dorian, MD, Michael Goldfarb, MD, MSc, Yanyan Gong, MSc, Michelle M. Graham, MD, Jing Gu, MD, PhD, Nathaniel M. Hawkins, MD, MPH, MBChB, Thao Huynh, MD, PhD, Karin H. Humphries, MBA, DSc, Maria Koh, MSc, Yoan Lamarche, MD, MSc, Laurie J. Lambert, PhD, Patrick R. Lawler, MD, MPH, Jean-Francois Légaré, MD, Hung Q. Ly, MD, Feng Qiu, MSc, Ata ur Rehman Quraishi, MBBS, Derek Y. So, MD, MSc, Robert C. Welsh, MD, Harindra C. Wijeysundera, MD, PhD, Graham Wong, MD, MPH, Andrew T. Yan, MD, FRCPC, Yana Gurevich, MD, MPH
Publikováno v:
CJC Open, Vol 3, Iss 8, Pp 1051-1059 (2021)
ABSTRACT: Background: Given changes in the care and outcomes of acute myocardial infarction (AMI) patients over the past several decades, we sought to develop prediction models that could be used to generate accurate risk-adjusted mortality and readm
Externí odkaz:
https://doaj.org/article/e1f4d1cbaf33463d98fa3d331f7b003f
Autor:
Quentin de Hemptinne, SM Hung Q. Ly Md, Jean-François Dorval, Fabien Picard, Jean-François Tanguay, Guillaume Marquis-Gravel, Robert Avram, Philippe L. L’Allier, Serge Doucet
Publikováno v:
Journal of Interventional Cardiology. 30:433-439
Aims Recent studies have shown favorable outcomes with everolimus-eluting bioresorbable vascular scaffold (BVS) in patients with stable coronary artery disease. Data on the use of BVS in saphenous vein graft disease (SVG) is currently lacking. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3068374ddb30fe0d0032b69b7707bb83
https://doi.org/10.1111/joic.12425
https://doi.org/10.1111/joic.12425
Publikováno v:
Catheterization and Cardiovascular Interventions. 90:598-611
Physiologic assessment using fractional flow reserve (FFR) to guide percutaneous coronary interventions (PCI) has been demonstrated to improve clinical outcomes, compared to angiography-guided PCI. Recently, resting indices such as resting Pd/Pa, "in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9996a0c13a0e7f0a01876174f14cad52
https://doi.org/10.1002/ccd.26933
https://doi.org/10.1002/ccd.26933
Autor:
Quentin de Hemptinne, Victor-Xavier Tadros, Guillaume Marquis-Gravel, Philippe L. L’Allier, Fabien Picard, SM Hung Q. Ly Md, Robert Avram, Jean-François Dorval, Jean-François Tanguay
Publikováno v:
Journal of interventional cardiology. 30(6)
Aims The management of patients with in-stent restenosis (ISR) is still a major clinical challenge even in the era of drug-eluting stents (DES). Recent studies have demonstrated acceptable clinical outcomes for the everolimus-eluting bioresorbable va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a3de02462e847aeb92bd12cb435819
https://pubmed.ncbi.nlm.nih.gov/28786151
https://pubmed.ncbi.nlm.nih.gov/28786151